Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. (Q47889408)

6 February 2018

title

Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. (English)

1 reference

6 February 2018

postmenopausal hormone-replacement therapy

1 reference

1 reference

3

1 reference

6 February 2018

author name string

Heikkinen AM

1

1 reference

6 February 2018

Niskanen L

2

1 reference

6 February 2018

Luoma J

4

1 reference

6 February 2018

Tuppurainen MT

5

1 reference

6 February 2018

Komulainen M

6

1 reference

6 February 2018

Saarikoski S

7

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

published in

Maturitas

1 reference

6 February 2018

volume

29

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

155-161

1 reference

6 February 2018

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Oestrogens and atherosclerotic vascular disease--local vascular factors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

The inhibition of low-density lipoprotein oxidation by 17-beta estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Menopause and risk of cardiovascular disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

Antibodies to oxidized low-density lipoprotein and to cardiolipin in nonpregnant and pregnant women with habitual abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900002-4

7 January 2021

10.1016/S0378-5122(98)00002-4

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9651905

1 reference

6 February 2018